Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP001150

Drug Information
Synonyms10262-69-8; HMS2089K11; MolPort-002-507-847; Spectrum2_000139; Spectrum3_000483; Prestwick1_000346; 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-; BSPBio_001945; NCGC00015708-10; 3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine; TBB066626; maprotiline; BSPBio_000411; Prestwick3_000346; SMR000641863; SMP1_000169; C07107; BPBio1_000453; DivK1c_000891; Prestwick2_000346; IDI1_000891; Maprotilinum [INN-Latin]; KBio3_001445; CID4011; 10347-81-6 (hydrochloride); 276-Ba; AC1L1H7N; Spectrum4_000035; AC-12507; CHEMBL21731; Maprotilina [INN-Spanish]; STOCK6S-18648; KBio1_000891; nchembio747-comp22; Maprotiline (USAN); Dibencycladine; KBio2_006503; 58902-67-3 (mesylate); D02566; EINECS 233-599-4; Maprotylina [Polish]; Maprotylina; KBio2_001367; LS-66338; KBio2_003935; BRD-K03319035-003-02-7; Spectrum5_000918; KBioGR_000469; BRD-K25433859-003-11-4; SPBio_002332; Ba-34,276; MLS001201766; Maprotiline [USAN:BAN:INN]; NCGC00024886-02; Tocris-0935; SPBio_000218; BA-34276; UNII-2U1W68TROF; NCGC00015708-01; N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine; Lopac-M-9651; Spectrum_000887; STK711156; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine; MolPort-002-671-472; Lopac0_000812; NCGC00024886-03; NCGC00016691-01; Maprotilin; AB00514665; NCGC00018217-01; 3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine; Deprilept; BRN 2385493; DB00934; L001173; CAS-10347-81-6; Maprotilinum; 9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-; NINDS_000891; NCGC00024886-01; KBioSS_001367; Maprotilina; Prestwick0_000346    
Trade NameDeprilept; Ludiomil; Psymion    
CompanyNorvatis Phamaceuticals Corporation    
IndicationDepressionApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntidepressants    
CAS NumberCAS 10262-69-8
PubChem Compound IDCID 4011.    
PubChem Substance IDSID 9318.    
SuperDrug ATC IDN06AA21;    
SuperDrug CAS ID010262698;    
TargetNorepinephrine reuptakeInhibitor[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 072284 To Reference
Ref 2Effect of pharmacologically selective antidepressants on serotonin uptake in rat platelets. Gen Physiol Biophys. 2005 Mar;24(1):113-28. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543